Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALTITUDE: Aliskiren in High-Risk Type 2 Diabetes
NCT00549757Phase 3Terminated
- Sponsor
- Novartis
- Start
- Oct 2007
- Primary completion
- Feb 2013
- Modality
- Small Molecules
- Countries
- 37
01
Overview
A Phase 3 trial of aliskiren in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started Oct 2007; status: terminated.
02
Drugs
aliskiren
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00549757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549757.